MedElevator Войти в исследования
← Поиск публикаций

DOI 10.4193/rhin26.159

Медицинская библиотека · Rhinology · 2026

When sleep improves but AHI does not: comments on mepolizumab +- FESS in severe CRSwNP.

Puhkala Jatta, Kukkonen-Harjula Katriina, Mansikkamäki Kirsi, Aittasalo Minna, Hublin Christer, Kärmeniemi Paula, Olkkonen Seppo, Partinen Markku, Sallinen Mikael, Tokola Kari, Fogelholm Mikael

КомментарийСтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVES

We conducted a randomized trial among overweight long-distance drivers to study the effects of structured lifestyle counseling on body weight and cardiometabolic risk factors.

METHODS

Men with waist circumference >100 cm were randomized into a lifestyle counseling (LIFE, N=55) and a reference (REF, N=58) group. The LIFE group participated in monthly counseling on nutrition, physical activity, and sleep for 12 months aiming at 10% weight loss. After 12 months, the REF group participated in 3-month counseling. Assessments took place at 0, 12, and 24 months. Between-group differences in changes were analyzed by generalized linear modeling. Metabolic risk (Z score) was calculated from components of metabolic syndrome.

RESULTS

The mean body weight change after 12 months was -3.4 kg in LIFE (N=47) and 0.7 kg in REF (N=48) [net difference -4.0 kg, 95% confidence interval (95% CI) -1.9- -6.2]. Six men in LIFE reduced body weight by ≥10%. Changes in waist circumference were -4.7 cm in LIFE and -0.1 cm in REF (net -4.7 cm, 95% CI -6.6- -2.7). Metabolic risk decreased more in the LIFE than REF group (net -1.2 points, 95% CI -0.6- -2.0). After 24 months follow-up, there were no between-group differences in changes in body weight (net -0.5 kg, 95% CI -3.8-2.9) or metabolic risk score (net 0.1 points; 95% CI -0.8-1.0) compared to baseline.

CONCLUSIONS

Weight reduction and decreases in cardiometabolic risk factors were clinically meaningful after 12 months of counseling.

Для цитирования: Puhkala Jatta, Kukkonen-Harjula Katriina, Mansikkamäki Kirsi, Aittasalo Minna, Hublin Christer, Kärmeniemi Paula, Olkkonen Seppo, Partinen Markku, Sallinen Mikael, Tokola Kari, Fogelholm Mikael. When sleep improves but AHI does not: comments on mepolizumab +- FESS in severe CRSwNP.. Rhinology. 2026. DOI: 10.4193/rhin26.159.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.